 |
N-(6-2-aminophenylamino)-6-oxohexyl)-4-methylbenzamide |
|---|---|
| Trade Name | |
| Orphan Indication | Friedreich Ataxia |
| USA Market Approval | USA |
| USA Designation Date | 2010-05-17 00:00:00 |
| Sponsor | Repligen Corporation;Building 1, Suite 100;Waltham, Massachusetts, 02453 |
| |
N-(6-2-aminophenylamino)-6-oxohexyl)-4-methylbenzamide |
|---|---|
| Trade Name | |
| Orphan Indication | Friedreich Ataxia |
| USA Market Approval | USA |
| USA Designation Date | 2010-05-17 00:00:00 |
| Sponsor | Repligen Corporation;Building 1, Suite 100;Waltham, Massachusetts, 02453 |